COPDの患者に、単一吸入器でのトリプル療法はLAMA/LABA、ICS/LABAの2剤療法と比べてCOPDの悪化率を低下させ、肺機能やQOLを改善した。 https://t.co/oWvLAvx69U PMID:31371939
RT @37phoenix: COPD患者に対するICS/LAMA/LABAの単一吸入器での治療はLAMA/LABAやICS/LABAと比べて急性増悪のリスクを減少させる。 Int J Chron Obstruct Pulmon Dis. 2019;14:1539 PMID:3…
COPD患者に対するICS/LAMA/LABAの単一吸入器での治療はLAMA/LABAやICS/LABAと比べて急性増悪のリスクを減少させる。 Int J Chron Obstruct Pulmon Dis. 2019;14:1539 PMID:31371939 https://t.co/XQdc2MD83Q
RT @JuanMarcoFigue1: In this metanalysis, no significant differences were found between triple therapy in a single inhaler and separate inh…
RT @JuanMarcoFigue1: In this metanalysis, no significant differences were found between triple therapy in a single inhaler and separate inh…
RT @JuanMarcoFigue1: In this metanalysis, no significant differences were found between triple therapy in a single inhaler and separate inh…
Personalizar manejo, ofrecer mejores y más sencillos tratamientos, vigilar técnica, manteniendo la máxima broncodilatacion.
RT @doclip1: This is why you should never believe meta-anlaysis https://t.co/cN1EKxAJia I rarely believe results of meta-analysis as ofte…
This is why you should never believe meta-anlaysis https://t.co/cN1EKxAJia I rarely believe results of meta-analysis as often the signal is biased by one trial A case in point is the meta-analysis comparing single triple (ICS/LABA/LAMA) vs single dual…h